latest news releases from the newsroom
Vodafone Sverige AB
Two Vodafone live mobile phones among the three top-selling mobiles
STOCKHOLM, Sweden, Aug. 12, 2003 (PRIMEZONE) -- A growing number of mobile phone users are keen to use pictures to communicate and to get mobile information in colour. Vodafone Sweden's (Other OTC:VODPF) (NYSE:VOD) sales list for July has the two Vodafone live mobiles: the Sony Ericsson T610 and the Sharp GX10I, among its three top-selling phones. In fact, eight of the ten mobile phones on the list now offer their users colour screens.
CrossGen Signs With Endeavor; Top Hollywood Agency Rounds Out Team of A-List Entertainment Business Professionals
TAMPA, Fla. and HOLLYWOOD, Calif., August 11, 2003 (PRIMEZONE) - CrossGen Entertainment, one of the world's leading publishers of comics and graphic novels, has been signed by Endeavor, widely considered one of the leading agencies in the entertainment industry, for representation in the world of film, television and video games, it was announced today.
Neoware Files $100 Million Shelf Registration
KING OF PRUSSIA, Pa., August 11, 2003 (PRIMEZONE) -- Neoware Systems, Inc. (Nasdaq:NWRE), the leading supplier of software, services, and thin client appliances, today announced that it has filed a Form S-3 shelf registration statement with the Securities and Exchange Commission (the "SEC"). Upon being declared effective by the SEC, the shelf registration statement would allow Neoware to issue common stock, preferred stock, debt securities, and warrants, from time to time, up to an aggregate of $100 million. The Company's shelf registration is part of a registration statement covering the registration for resale by selling stockholders of 1,500,000 shares which, as previously announced, were recently sold in a private placement.
Brower Piven, A Professional Corporation
Law Offices of Charles J. Piven, P.A. Announces Class Action Lawsuit Against CV Therapeutics, Inc. -- CVTX
BALTIMORE, August 11, 2003 (PRIMEZONE) -- Law Offices Of Charles J. Piven, P.A. today announced that a securities class action has been commenced on behalf of shareholders who purchased, converted, exchanged or otherwise acquired the common stock of CV Therapeutics, Inc. (Nasdaq:CVTX) between May 14, 2003 and August 1, 2003, inclusive (the "Class Period").